Fresenius SE & Co. KGaA, DE0005785604

Fresenius stock slips as Xetra quote stays below targets

Published on 09/02/2026 at 06:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Fresenius stock traded at EUR 45.25 on Xetra as of August 31, 2026, while the latest quoted target stood at EUR 55.90. The gap keeps valuation in view for investors.

Flatlay-Arrangement rund um Trinknahrung mit passenden Requisiten von oben, neutral
Flatlay-Arrangement rund um Trinknahrung zum Thema Fresenius Kabi, ISIN DE0005785604, weiches Oberlicht, Illustration mit AI erstellt.

Fresenius stock (ISIN DE0005785604) traded at EUR 45.25 on Xetra on August 31, 2026, after a daily loss of 1.33 percent. The same session showed a low of EUR 45.245, a high of EUR 46.000 and volume of 1.04 million shares.

Target gap stays visible

According to the latest market snapshot on August 31, 2026, the average 12-month target for Fresenius stood at EUR 55.90, which leaves a gap of EUR 10.65, or 23.54 percent, versus the Xetra close. That difference is the main valuation anchor in the current trading setup.

The share also compared with a 52-week range of EUR 35.11 to EUR 52.96, putting the latest close closer to the upper half of that band than to the yearly low. A DAX listing adds the domestic market context.

Latest reported numbers

For Q2 FY26, Fresenius reported revenue of EUR 5.95 billion and earnings of EUR 382 million, with revenue above the consensus estimate of EUR 5.95 billion shown in the same data set and earnings per share at 0.83 versus an estimate of 0.89. The reported profit margin was 6.43 percent.

On a trailing basis, the same source lists revenue of EUR 23.28 billion, net income attributable to common shareholders of EUR 1.56 billion and diluted EPS of 2.77. For investors, the comparison between Q2 FY26 and trailing figures makes margin delivery and cash conversion the key points to watch.

Go deeper

Fresenius shares and latest market data

The latest quote, the target gap and the Q2 FY26 figures are enough to frame the stock's current setup.

Helios and Kabi

Fresenius SE & Co. KGaA operates through Fresenius Kabi and Fresenius Helios, with the group based in Bad Homburg vor der Hohe and 178,486 full-time employees listed in the profile data. The business mix still centers on medical care facilities, therapies and services for chronically ill patients.

Stock level and setup

As of August 31, 2026, the Xetra quote was EUR 45.25, with an ask of EUR 45.58 and a previous close of EUR 45.24. The stock traded below the EUR 55.59 average target and within a one-day range of EUR 45.24 to EUR 46.00.

Company: Fresenius SE & Co. KGaA
ISIN: DE0005785604
Ticker: FRE
Trading venue: Xetra
Price (as of August 31, 2026, 5:35 PM): EUR 45.25
Sector / Industry: Healthcare / Medical Care Facilities
Index membership: DAX
Market capitalization: EUR 25.6 billion (as of August 31, 2026)

Disclaimer...

en | DE0005785604 | FRESENIUS SE & CO. KGAA | boerse | 70041002 | bgmi